Antibody cocktails: next-generation biopharmaceuticals with improved potency
- 1 September 2007
- journal article
- review article
- Published by Elsevier BV in Trends in Biotechnology
- Vol. 25 (9), 390-394
- https://doi.org/10.1016/j.tibtech.2007.07.005
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Production of target‐specific recombinant human polyclonal antibodies in mammalian cellsBiotechnology & Bioengineering, 2006
- Synergistic Antitumor Effects of Combined Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor-2 Targeted TherapyClinical Cancer Research, 2006
- Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant PatientsJournal of Virology, 2006
- Human antibodies from transgenic animalsNature Biotechnology, 2005
- A Fully Human Recombinant IgG-like Bispecific Antibody to Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor for Enhanced Antitumor ActivityPublished by Elsevier BV ,2005
- Tunable antibodiesNature Biotechnology, 2005
- Protection against Pneumococcal Pneumonia in Mice by Monoclonal Antibodies to PneumolysinInfection and Immunity, 2004
- Preclinical Evaluation of Two Human Anti–Hepatitis B Virus(HBV) Monoclonal Antibodies in the HBV-Trimera Mouse Model and in HBV Chronic Carrier ChimpanzeesHepatology, 2000
- Comparison of Antigenic Sites of Subtype-specific Respiratory Syncytial Virus Attachment ProteinsJournal of General Virology, 1989
- Synergistic Neutralization of Rubella Virus by Monoclonal Antibodies to Viral HaemagglutininJournal of General Virology, 1987